Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Litigation Details for Gilead Sciences, Inc. v. Natco Pharma Limited (Fed. Cir. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Gilead Sciences, Inc. v. Natco Pharma Limited
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Gilead Sciences, Inc. v. Natco Pharma Limited (Fed. Cir. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-09-17 26 of U.S. Patent No. 5,763,483 (“the ’483 patent”). Gilead Sciences owns the ’483 patent, titled… ’483 patent—obviousness-type double patenting over the claims of commonly-owned U.S. Patent No. 5,952,375…that the ’375 patent may serve as a double-patenting reference against the ’483 patent. Gilead submitted…also issued a patent on the ’946 application—U.S. Patent No. 5,866,601 (“the ’601 patent”). (A309.) …the ’375 patent can be used as a reference patent for purposes of determining if the ’483 patent is an External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.